Target intelligence / Profile preview

Stomatin-like protein 3 (STOML3)

Target
STOML3
Molecular classification
Integral membrane protein, Stomatin-domain family, SPFH domain-containing protein (Stomatin/Prohibitin/Flotillin/HflK/C)
01

Overview

Stomatin-like protein 3 (STOML3) is an integral membrane protein that belongs to the stomatin-domain family, characterized by a conserved core stomatin domain and a short hydrophobic hairpin responsible for membrane insertion[1][3][4]. STOML3 is predominantly expressed in sensory neurons—including olfactory sensory neurons and dorsal root ganglia—where it is essential for normal touch sensation and mechanosensory transduction[3][4]. It forms complexes with other stomatin-domain proteins and modulates the activity of key mechanosensitive ion channels such as ASICs (acid-sensing ion channels) and Piezo channels, thereby regulating neuronal sensitivity to mechanical and chemical stimuli[1][2][3]. STOML3 acts, at least in part, by binding membrane cholesterol, increasing membrane stiffness, and enabling efficient force transfer to mechanosensitive ion channels[2]. Its loss impairs sensory neuron function and mechanosensation, leading to decreased neuronal excitability and blunted perception of touch or pain, as shown in knockout models[2][4]. STOML3’s role in mechanotransduction and pain pathways makes it a candidate therapeutic target for managing chronic pain syndromes[2]. No specific drugs are yet marketed to target STOML3, but its mechanistic pathway is seen as a potential strategy for modulation of chronic pain[2].

Other names
Stomatin-like protein 3STOML3SLP-3SROEpb7.2lEPB72-like 3protein 7.2Berythrocyte band 7 integral membrane proteinstomatin (EPB72)-like 3
02

Mechanism of action

Modulates membrane mechanics by binding cholesterol; Facilitates force transfer to, and tunes, mechanosensitive ion channels (notably Piezo1, Piezo2, ASICs)

03

Biological functions

Mechanosensation/mechanotransductionModulation of ion channel activity (ASICs, Piezo channels)Regulation of sensory neuron sensitivityModulation of spontaneous and evoked firing in olfactory sensory neuronsVesicular transport in neurons
04

Disease associations

Chronic pain (mechanosensitivity, tactile allodynia)Sensory transduction disorders
05

Safety considerations

No drug safety or therapeutic risks described; target is under investigation for chronic pain, with limited clinical translation to date
06

Biomarkers

STOML3 expression may mark subsets of sensory neurons; specific biomarker use is not established

Beyond the preview

Go deeper on Stomatin-like protein 3 (STOML3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stomatin-like protein 3 (STOML3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call